Skip to main content
Q

Qiagen

Qiagen provides a portfolio of sample‑preparation kits, automated extraction platforms like QIAsymphony Connect, and digital PCR instruments such as QIAcuityDx to streamline nucleic‑acid purification and molecular testing. Its solutions integrate liquid‑handling automation, built‑in quality controls, and AI‑driven software for assay design, data acquisition, and result interpretation, enabling high‑throughput, reproducible workflows for clinical diagnostics, research, and biotech labs.

Venlo, NL,DE,GB,US,CA,MX,BR,AU,MY,SG,TH,PH,TW,CN,KR,JP,IN,AE,ZA,EG,TR,SE,DK,PL,FR,CH,IT,ESFounded 19845.5K50K+ followers
Updated 2 months ago

Funding

$750M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Clinical and research laboratories face time‑consuming, error‑prone nucleic‑acid extraction and molecular testing workflows, which can delay diagnoses and limit throughput for infectious disease, oncology, and transplant monitoring.

Solution

Qiagen offers a portfolio of sample‑preparation kits, automated extraction platforms such as QIAsymphony Connect, and dedicated instruments like the QIAcuityDx digital PCR system to streamline nucleic‑acid purification and analysis. The solutions integrate automated liquid handling, built‑in quality controls, and software that manages assay setup, data acquisition, and result interpretation. Cloud‑enabled analytics and AI tools further accelerate assay development and support clinical decision‑making. By providing end‑to‑end kits, instruments, and digital tools, Qiagen reduces hands‑on time, improves reproducibility, and enables high‑throughput testing across a range of molecular applications.

Target Audience

Primary customers are clinical diagnostic laboratories, academic and pharmaceutical research labs, and biotech companies that require reliable, high‑throughput molecular testing and automation.

Features

  • QIAsymphony Connect: fully automated, high‑yield nucleic‑acid extraction for IVD and research workflows
  • QIAcuityDx digital PCR: walk‑away multiplexed quantification with integrated partitioning, thermocycling, and imaging
  • Comprehensive sample‑prep kits covering DNA, RNA, plasmid, and microbial nucleic acids
  • AI‑driven assay design and result interpretation tools accessible via web dashboards
  • Compatibility with standard lab formats (96‑well plates, nanoplates) and seamless data export to LIMS/EHR systems
  • Modular instrument ecosystem allowing scaling from single‑sample to high‑throughput operations
This profile is AI-generated and may contain inaccuracies.